Observational studyJournal of cardiovascular electrophysiology2026
Same-Day Discharge in Ventricular Ablation: Safety Outcomes and Case Selection.
Observational study in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Same-Day Discharge in Ventricular Ablation: Safety Outcomes and Case Selection.Journal of cardiovascular electrophysiology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCatheter ablation (CA) of ventricular arrhythmias (VA) has traditionally entailed an overnight stay, and little has been published on outcomes of same-day discharge (SDD) in this population. Thus far, no comparative study of SDD in VA ablation has been described.
methodsThis was a single-center prospective comparative observational study of 255 consecutive patients undergoing elective CA of VA (PVC or VT) in the outpatient setting between April 2023 and June 2025. We excluded patients who were pre-admitted or planned for admission or overnight stays post-ablation. SDD was at the attending physician's discretion. Post-discharge, patients had routine telephone follow-up to monitor for complications.
resultsAmong 255 patients undergoing ablation for ventricular arrhythmia, 123 (48%) underwent SDD. Patients undergoing SDD had a mean age of 61 ± 16, 38% were female, 33% had heart failure, and the majority had CA for PVC (96%). Compared with those who stayed overnight, SDD patients had higher EF (50% vs. 46%, p = 0.003), less arterial access (48% vs. 62%, p = 0.02), and lower PAINESD score (3.4 vs. 4.8, p = 0.04). Over 30 days of follow-up, two patients (1.6%) had major access site complications, and one (0.8%). Based upon these observations, we describe favorable characteristics for SDD in CA of VA, with the key features of including low-to-moderate risk patients, early case timing, liberal closure device usage, and close follow-up by a dedicated clinical nurse.
conclusionSDD is feasible and safe for patients undergoing PVC ablation and potentially a subset of patients undergoing VT ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.